| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.58 | 0.04 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |